The Effective Statistician - in association with PSI
The FDA is developing a series of four methodological patient-focused drug development (PFDD) guidance documents to address, in a stepwise manner, how stakeholders can collect and submit patient...
What is a DIGA?
Why is Germany so important for DIGAs?
Nowadays, there are a couple of available apps being used in several countries that collect user information, such as heart r...
Why do companies want to develop new patient-reported outcomes?
How does the process start when we want to develop a new questionnaire?
What are the key areas to look into for unders...
What is medical affairs? Launch and Lifecycle?
How has this area evolved over the last 2 decades?
What is the current state across the industry in terms of the role of statistics in ...
When there is one topic, which is really hot, it's causal inference. I've got in contact with it about 20 years ago when analysing observational studies and when nobody working on clinical trial...
The guest in this episode represents the sponsor of this show – Nigel Howitt – current chair of PSI.
In the modern workplace, conflict has become a difficult topic. After all, conflict is antithetical to teamwork, employee engagement, and a positive company culture. Or is it?
"No" is a ...
Subgroup analyses in combination with data visualisation is one of the hottest topics I can think about. And it hits us as statisticians during our careers again and again.
We need to un...
Publishing data is great, but we also want to measure the impact our work has beyond the additional entry in our CVs. During this episode, Mike and I discuss the tools Altmetric and Dimensions. ...
We leverage Real World Evidence in many different areas and there's are many different things that can go wrong with this.
In today's episode, Rachel and I will discuss the things that w...